M42, Inocras, MRDVision, Molecular Residual Disease, MRD Testing, Cancer Recurrence, Breast Cancer, Triple-Negative Breast Cancer, HER2-Positive Breast Cancer, Whole-Genome Sequencing,

ABU DHABI, United Arab Emirates — October 23, 2026 M42 and Inocras have announced a strategic collaboration to advance...